SiteOne Therapeutics Funding: $100M Raised, Series C (2024)
SiteOne Therapeutics is based in San Francisco. It has raised $100M in total funding. Latest round: Series C.
SiteOne Therapeutics funding overview
SiteOne Therapeutics is based in San Francisco. SiteOne Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2024. The round record for SiteOne Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital, BSQUARED Capital. 5 distinct backers are named across the disclosed rounds.
SiteOne Therapeutics at a glance
Total raised
$100M
Latest round
Series C
Latest round date
December 2024
Headquarters
San Francisco
Notable investors
Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital, BSQUARED Capital
Frequently asked about SiteOne Therapeutics funding
How much has SiteOne Therapeutics raised?
SiteOne Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in SiteOne Therapeutics?
Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital, BSQUARED Capital are named among the investors backing SiteOne Therapeutics.
What was the latest SiteOne Therapeutics funding round?
The most recent disclosed round is a Series C, announced in December 2024.
Where is SiteOne Therapeutics based?
SiteOne Therapeutics is based in San Francisco.
When did SiteOne Therapeutics last raise?
The last disclosed SiteOne Therapeutics round closed in December 2024 at Series C.
We update the SiteOne Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.
